Details for Patent: 7,790,899
✉ Email this page to a colleague
Title: | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and crystalline forms |
Abstract: | Disclosed herein are methods for synthesizing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide. Also disclosed herein is the hemi-tartrate salt of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)-p- henylmethyl)carbamide and methods for obtaining the salt. Further disclosed are various crystalline forms of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its hemi-tartrate salt including various polymorphs and solvates. |
Inventor(s): | Tolf; Bo-Ragnar (Malmo, SE), Schlienger; Nathalie (Frederiksberg, DK), Thygesen; Mikkel Boas (Copenhagen, DK) |
Assignee: | ACADIA Pharmaceuticals, Inc. (San Diego, CA) |
Filing Date: | May 15, 2007 |
Application Number: | 11/749,115 |
Claims: | 1. A method of synthesizing N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyl- oxy)phenylmethyl)carbamide, comprising: reacting 4-hydroxybenzaldehyde with isobutylbromide in the presence of dimethylformamide, potassium iodide and potassium carbonate to produce 4-isobutoxybenzaldehyde; reacting the 4-isobutoxybenzaldehyde with about 1.5 equivalents of NH.sub.2OH to produce 4-isobutoxybenzoxime; reacting the 4-isobutoxybenzoxime with H.sub.2 in the presence of Raney-Ni and from about 13 to about 16 equivalents of NH.sub.3 to produce (4-isobutoxyphenyl)methanamine; adding acetic acid to produce (4-isobutoxyphenyl)methanamine acetate; treating the (4-isobutoxyphenyl)methanamine acetate with about 30% NaOH and extracting with toluene to produce (4-isobutoxyphenyl)methanamine; reacting the (4-isobutoxyphenyl)methanamine with HCl and COCl.sub.2 in the presence of toluene to produce 1-isobutoxy-4-(isocyanatomethyl)benzene; and reacting a solution of the 1-isobutoxy-4-(isocyanatomethyl)benzene in toluene with N-(4-fluorobenzyl)-1-methylpiperidin-4-amine to produce N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyl- oxy)phenylmethyl)carbamide. 2. The method of claim 1, further comprising forming a tartrate salt of N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyl- oxy)phenylmethyl)carbamide, and seeding the formed N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyl- oxy)phenylmethyl)carbamide tartrate with crystalline Form C of N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyl- oxy)phenylmethyl)carbamide tartrate to produce crystalline Form C of N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyl- oxy)phenylmethyl)carbamide tartrate. 3. The method of claim 2, wherein the product of the method comprises less than about 0.2% by weight of Impurity 1: ##STR00034## 4. The method of claim 2, wherein the product of the method comprises less than about 0.1% by weight of Impurity 2: ##STR00035## 5. The method of claim 2, wherein the product of the method comprises substantially no Impurity 2. 6. The method of claim 2, wherein the crystalline Form C of N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyl- oxy)phenylmethyl)carbamide tartrate is present in amounts of at least about 90%. 7. The method of claim 6, wherein the crystalline Form C of N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyl- oxy)phenylmethyl)carbamide tartrate is present in amounts of at least about 95%. 8. The method of claim 6, wherein the crystalline Form C of N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyl- oxy)phenylmethyl)carbamide tartrate is present in amounts of at least about 98%. 9. The method of claim 2, wherein the product of the method comprises substantially no Impurity 1. |